title: [Achievement of therapeutic objectives].
abstract: Therapeutic objectives for patients with atherogenic dyslipidemia are achieved by improving patient compliance and adherence. Clinical practice guidelines address the importance of treatment compliance for achieving objectives. The combination of a fixed dose of pravastatin and fenofibrate increases the adherence by simplifying the drug regimen and reducing the number of daily doses. The good tolerance, the cost of the combination and the possibility of adjusting the administration to the patient's lifestyle helps achieve the objectives for these patients with high cardiovascular risk.
authors.affiliation: Medicina de Familia, Centro de Salud Prosperidad, Madrid, España. Electronic address: tmantilla5@yahoo.es.
authors.forename: Teresa
authors.initials: T
authors.lastname: Mantilla
mesh_terms: D050197:Atherosclerosis / Q000209:etiology / Q000517:prevention & control*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D004334:Drug Administration Schedule; D004338:Drug Combinations; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy*; D011345:Fenofibrate / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D055118:Medication Adherence; D017035:Pravastatin / Q000008:administration & dosage / Q000627:therapeutic use*; D012307:Risk Factors
chemical_list: D004338:Drug Combinations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D017035:Pravastatin; D011345:Fenofibrate
keywords: Atherogenic dyslipidemia; Combinación; Combination; Compliance; Cumplimiento; Dislipemia aterogénica; Objetivos terapéuticos; Therapeutic objectives